SPDR S&P Biotech ETF $XBI Shares Purchased by IFP Advisors Inc

IFP Advisors Inc boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 20.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,192 shares of the exchange traded fund’s stock after buying an additional 3,590 shares during the quarter. IFP Advisors Inc’s holdings in SPDR S&P Biotech ETF were worth $3,354,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Axiom Investment Management LLC acquired a new position in shares of SPDR S&P Biotech ETF during the first quarter valued at approximately $26,000. Financial Life Planners acquired a new stake in shares of SPDR S&P Biotech ETF in the first quarter worth approximately $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $27,000. Angeles Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the second quarter worth approximately $28,000. Finally, Intesa Sanpaolo Wealth Management purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth approximately $30,000.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $156.82 on Friday. The business has a fifty day moving average price of $158.35 and a 200 day moving average price of $141.62. SPDR S&P Biotech ETF has a one year low of $92.64 and a one year high of $169.89. The company has a market cap of $10.24 billion, a P/E ratio of 11.47 and a beta of 0.84.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.